Prof. Sanchez & Dr Montaner Villalonga are recognized as Key Opinion Leaders in the field of brain biomarkers. They combine their unique expertise in brain biomarker discovery, awareness and clinical validation.

Their continuous discoveries of novel brain biomarkers constitute the IP portfolio of ABCDx and allow a rapid access to clinical validation for ABCDx’s medical devices.